FI941628A0 - Seos verenvuodon tyrehdyttämiseksi paikallisesti - Google Patents

Seos verenvuodon tyrehdyttämiseksi paikallisesti

Info

Publication number
FI941628A0
FI941628A0 FI941628A FI941628A FI941628A0 FI 941628 A0 FI941628 A0 FI 941628A0 FI 941628 A FI941628 A FI 941628A FI 941628 A FI941628 A FI 941628A FI 941628 A0 FI941628 A0 FI 941628A0
Authority
FI
Finland
Prior art keywords
locally
mixture
stop bleeding
bleeding
stop
Prior art date
Application number
FI941628A
Other languages
English (en)
Swedish (sv)
Other versions
FI941628A (fi
Inventor
Ulla Karin Elisabeth Hedner
Erik Oestergaard
Martin William Edvards
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI941628A0 publication Critical patent/FI941628A0/fi
Publication of FI941628A publication Critical patent/FI941628A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI941628A 1991-10-11 1994-04-08 Seos verenvuodon tyrehdyttämiseksi paikallisesti FI941628A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77566491A 1991-10-11 1991-10-11
PCT/DK1992/000296 WO1993006855A1 (en) 1991-10-11 1992-10-09 Hemostatic composition for local hemostasis

Publications (2)

Publication Number Publication Date
FI941628A0 true FI941628A0 (fi) 1994-04-08
FI941628A FI941628A (fi) 1994-06-08

Family

ID=25105103

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941628A FI941628A (fi) 1991-10-11 1994-04-08 Seos verenvuodon tyrehdyttämiseksi paikallisesti

Country Status (9)

Country Link
EP (1) EP0613377A1 (fi)
JP (1) JPH07500095A (fi)
AU (1) AU2793292A (fi)
CA (1) CA2121028A1 (fi)
CZ (1) CZ83194A3 (fi)
FI (1) FI941628A (fi)
HU (1) HUT67693A (fi)
NO (1) NO941285L (fi)
WO (1) WO1993006855A1 (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2227542T3 (es) * 1993-11-03 2005-04-01 Clarion Pharmaceuticals, Inc. Parche hemostatico.
DE19903693A1 (de) * 1998-04-24 1999-10-28 Centeon Pharma Gmbh Protease zur Aktivierung des Gerinnungsfaktors VII
FR2754183A1 (fr) * 1996-10-08 1998-04-10 Lefebvre Jean Marie Composition visqueuse hemostatique, notamment a l'etat de gel
DE19710190A1 (de) * 1997-03-12 1998-09-17 Immuno Ag Aktivierter Vitamin K-abhängiger Blutfaktor und Verfahren zu dessen Herstellung
AU7907398A (en) * 1997-06-23 1999-01-04 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
CN100411684C (zh) * 1999-07-14 2008-08-20 诺沃挪第克健康护理股份公司 FVIIa或组织因子拮抗剂在调节基因表达和细胞迁移或趋化中的应用
GB0011053D0 (en) 2000-05-09 2000-06-28 Hudson John O Medical device and use thereof
EP1282438B1 (en) * 2000-05-10 2005-08-03 Novo Nordisk Health Care AG Use of pharmaceutical composition comprising a factor viia and a factor xiii
US7015194B2 (en) 2000-05-10 2006-03-21 Novo Nordisk A/S Pharmaceutical composition comprising factor VIIa and anti-TFPI
DE50012119D1 (de) * 2000-09-22 2006-04-13 Perlei Medical Producte Gmbh Verwendung von Antifibrinolytika für die Präparation und Herstellung von Tupfern, Kompressen oder Pflaster
JP2005508985A (ja) * 2001-11-09 2005-04-07 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Ｖｉｉ因子ポリペプチドおよびアプロチニンポリペプチドを含む薬学的組成物
US7125846B2 (en) 2001-11-09 2006-10-24 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
EP1446148A1 (en) * 2001-11-09 2004-08-18 Novo Nordisk A/S Pharmaceutical composition comprising a factor vii polypeptide and epsilon-aminocapronic acid
US7078479B2 (en) 2001-11-09 2006-07-18 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptides
US7291587B2 (en) 2001-11-09 2007-11-06 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides
WO2003039581A1 (en) * 2001-11-09 2003-05-15 Novo Nordisk Health Care Ag Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid
JP2005510513A (ja) 2001-11-09 2005-04-21 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Ｖｉｉ因子ポリペプチドおよびｔａｆｉポリペプチドを含む薬学的組成物
GB2409162B (en) * 2004-10-06 2005-12-14 Bhk Holding Ltd Materials,methods,and apparatus for treating a body cavity
AR048742A1 (es) * 2004-12-22 2006-05-24 Gador Sa Sistema de aplicacion de medicamentos intra-oral
FR2894831B1 (fr) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
EP2004214B1 (en) * 2006-03-16 2012-11-07 STELLARIS PHARMACEUTICALS Aps Local treatment with factor vii
GB2447012B (en) * 2007-02-21 2011-03-16 Pharmacure Health Care Ab Composition for combating epistaxis
EP2259803B2 (en) 2008-02-29 2019-03-13 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
ES2421642T3 (es) * 2008-03-03 2013-09-04 Omrix Biopharmaceuticals Ltd Una esponja de gelatina que comprende un ingrediente activo, su preparación y uso
RU2501556C2 (ru) * 2011-10-06 2013-12-20 Владимир Лазаревич Адамян Кровоостанавливающая спичка
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
RU2636240C2 (ru) 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
RU2700162C2 (ru) 2013-06-21 2019-09-13 Ферросан Медикал Дивайсиз А/С Расширенная под вакуумом сухая композиция и шприц для ее сохранения
EP3079731B1 (en) 2013-12-11 2018-08-08 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
BR112017007466B1 (pt) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
WO2016102446A1 (en) 2014-12-24 2016-06-30 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
KR102641229B1 (ko) * 2015-09-01 2024-02-29 백스터 인터내셔널 인코포레이티드 지혈 물질
KR20210008479A (ko) 2018-05-09 2021-01-22 훼로산 메디칼 디바이스 에이/에스 지혈 조성물을 제조하는 방법
CN115605234A (zh) * 2019-12-25 2023-01-13 广州倍绣生物技术有限公司（Cn） 止血糊剂及其用途
WO2024042148A1 (en) 2022-08-26 2024-02-29 Stellaris Pharmaceuticals Aps Haemorrhage inhibiting compositions and methods involving the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
AU593042B2 (en) * 1985-11-26 1990-02-01 Novo Nordisk Health Care Ag Compositions and methods for the treatment of bleeding disorders

Also Published As

Publication number Publication date
CA2121028A1 (en) 1993-04-15
NO941285D0 (no) 1994-04-08
NO941285L (no) 1994-06-07
EP0613377A1 (en) 1994-09-07
HU9401008D0 (en) 1994-07-28
HUT67693A (en) 1995-04-28
FI941628A (fi) 1994-06-08
JPH07500095A (ja) 1995-01-05
WO1993006855A1 (en) 1993-04-15
CZ83194A3 (en) 1994-11-16
AU2793292A (en) 1993-05-03

Similar Documents

Publication Publication Date Title
FI941628A0 (fi) Seos verenvuodon tyrehdyttämiseksi paikallisesti
DK44389D0 (da) Synergisk antioxidantblanding
BR9205781A (pt) Composição processo para produzir a composição
BR9205672A (pt) Composição gasosa
KR900011269A (ko) 멀티 스크린 수행방법
NO933800L (no) Partikkelformig vaskemiddelblanding
DE69123856T2 (de) Befestigungselemente
BR8901146A (pt) Pa para helice carenada
DE69229332T2 (de) Positiv-arbeitende Resistzusammensetzung
DE69209356T2 (de) Positiv-arbeitende Resistzusammensetzung
DE69223083D1 (de) Positivarbeitende Resistzusammensetzung
BR7002423U (pt) Disposicao construtiva aplicada a lacre
DE69213996T2 (de) Positivarbeitende Resistzusammensetzung
BR7101923U (pt) Disposicao proporcionada a abaco
BR7100634U (pt) Disposicao proporcionada a techadura
BR7100729U (pt) Disposicao proporcionada a estrutura para reboques
BR7101317U (pt) Disposicao proporcionada a canivete
BR6900532U (pt) Disposicao construtiva aplicada a fivela
BR7201288U (pt) Disposicao proporcionada a sematoro
BR7100021U (pt) Disposicao construtiva aplicada a caixa-arquivo
BR7100539U (pt) Disposicao construtiva aplicada a cortador automatico de tijolos
KR930012914U (ko) 조립식 탁자
IT89067917A1 (it) Orinale a perdere
BR7100945U (pt) Dispositivo para cortar laminados decorativos
BR7101586U (pt) Ralinho para calcanhar

Legal Events

Date Code Title Description
FD Application lapsed